|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2011-1-28
|
|
pubmed:abstractText |
To date, treatment with intravenous (IV) agents such as vasodilators, diuretics, and inotropes has shown marginal or mixed benefits in acute heart failure (AHF) trials. The aim of this study was to identify the risks and benefits of IV drugs in patients hospitalized with acute decompensated heart failure.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1432-1238
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
37
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
290-301
|
|
pubmed:meshHeading |
pubmed-meshheading:21086112-Acute Disease,
pubmed-meshheading:21086112-Adolescent,
pubmed-meshheading:21086112-Adult,
pubmed-meshheading:21086112-Aged,
pubmed-meshheading:21086112-Aged, 80 and over,
pubmed-meshheading:21086112-Female,
pubmed-meshheading:21086112-Health Care Surveys,
pubmed-meshheading:21086112-Heart Failure,
pubmed-meshheading:21086112-Hospital Mortality,
pubmed-meshheading:21086112-Hospitalization,
pubmed-meshheading:21086112-Humans,
pubmed-meshheading:21086112-Internationality,
pubmed-meshheading:21086112-Male,
pubmed-meshheading:21086112-Middle Aged,
pubmed-meshheading:21086112-Propensity Score,
pubmed-meshheading:21086112-Registries,
pubmed-meshheading:21086112-Survival Analysis,
pubmed-meshheading:21086112-Young Adult
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Short-term survival by treatment among patients hospitalized with acute heart failure: the global ALARM-HF registry using propensity scoring methods.
|
|
pubmed:affiliation |
Department of Anesthesiology and Critical Care Medicine, Hôpital Lariboisère, L'Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France. alexandre.mebazaa@lrb.aphp.fr
|
|
pubmed:publicationType |
Journal Article
|
